PERKINS CAPITAL MANAGEMENT INC - Q2 2022 holdings

$96.6 Million is the total value of PERKINS CAPITAL MANAGEMENT INC's 105 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 19.4% .

 Value Shares↓ Weighting
INUV BuyINUVO INC$2,877,000
+1.2%
5,812,672
+0.1%
2.98%
+27.8%
VCYT BuyVERACYTE INC$2,550,000
-24.8%
128,130
+4.2%
2.64%
-5.0%
AXGN BuyAXOGEN INC$2,506,000
+9.5%
305,940
+6.2%
2.59%
+38.3%
NTRA BuyNATERA INC$2,293,000
-3.5%
64,700
+10.8%
2.37%
+21.9%
QUIK BuyQUICKLOGIC CORP$2,122,000
+56.4%
250,285
+1.4%
2.20%
+97.6%
STRM BuySTREAMLINE HEALTH SOLUTIONS$2,106,000
-20.6%
1,658,140
+0.1%
2.18%
+0.3%
BTTR BuyBETTER CHOICE CO INC$1,853,000
+8.4%
842,250
+25.7%
1.92%
+36.9%
NEO BuyNEOGENOMICS INC$1,651,000
-10.9%
202,550
+32.8%
1.71%
+12.5%
CTLP BuyCANTALOUPE INC$1,513,000
-13.4%
270,125
+4.6%
1.57%
+9.3%
XGN BuyEXAGEN INC$1,360,000
-15.7%
236,975
+17.9%
1.41%
+6.4%
CDNA BuyCAREDX INC$1,256,000
-41.1%
58,492
+1.4%
1.30%
-25.7%
ATEC BuyALPHATEC HLDGS INC$1,233,000
-38.6%
188,500
+8.0%
1.28%
-22.4%
FPAY BuyFLEXSHOPPER INC$1,213,000
-47.2%
1,347,940
+0.4%
1.26%
-33.3%
MGNI BuyMAGNITE INC$1,208,000
+288.4%
136,025
+478.2%
1.25%
+390.2%
BuyACHIEVE LIFE SCIENCES INC$1,113,000
-15.8%
228,100
+30.6%
1.15%
+6.3%
ISR BuyISORAY INC$901,000
-11.3%
2,914,500
+4.1%
0.93%
+12.0%
T BuyAT&T INC$871,000
-7.4%
41,537
+4.3%
0.90%
+17.0%
AKTS BuyAKOUSTIS TECHNOLOGIES INC$836,000
-33.9%
225,950
+16.2%
0.86%
-16.5%
BuyJOURNEY MED CORP$823,000
-11.1%
220,050
+14.8%
0.85%
+12.3%
AUGX BuyAUGMEDIX INC$791,000
-37.3%
439,500
+2.4%
0.82%
-20.8%
BuyMDXHEALTH SAsponsored ads$755,000
+1.1%
90,458
+0.5%
0.78%
+27.8%
FBIO BuyFORTRESS BIOTECH INC$639,000
+356.4%
760,992
+640.2%
0.66%
+474.8%
NewBIOLASE INC$542,000118,300
+100.0%
0.56%
AQB BuyAQUABOUNTY TECHNOLOGIES INC$510,000
-2.5%
298,500
+6.8%
0.53%
+23.1%
DCI BuyDONALDSON INC$480,000
-3.4%
9,967
+4.2%
0.50%
+22.1%
NewROCKWELL MED INC$458,000355,052
+100.0%
0.47%
BLFS BuyBIOLIFE SOLUTIONS INC$442,000
-7.3%
32,000
+52.4%
0.46%
+17.1%
CSII BuyCARDIOVASCULAR SYS INC DEL$362,000
-34.5%
25,200
+3.1%
0.38%
-17.2%
AGFY BuyAGRIFY CORP$353,000
-37.2%
179,185
+47.7%
0.36%
-20.8%
KERN NewAKERNA CORP$300,0002,173,000
+100.0%
0.31%
TCMD BuyTACTILE SYS TECHNOLOGY INC$241,000
-29.5%
32,967
+94.3%
0.25%
-11.1%
VVOS BuyVIVOS THERAPEUTICS INC$211,000
-47.5%
163,800
+9.2%
0.22%
-33.9%
IRIX BuyIRIDEX CORP$206,000
-35.8%
80,346
+15.9%
0.21%
-19.0%
LUMN BuyLUMEN TECHNOLOGIES INC$144,000
+0.7%
13,200
+3.9%
0.15%
+27.4%
APYX BuyAPYX MEDICAL CORPORATION$127,000
+89.6%
21,600
+109.7%
0.13%
+138.2%
VRAY BuyVIEWRAY INC$115,000
-11.5%
43,500
+31.0%
0.12%
+11.2%
NewSHARPS TECHNOLOGY INC$91,00094,500
+100.0%
0.09%
NBSE BuyNEUBASE THERAPEUTICS INC$86,000
-31.2%
81,500
+22.6%
0.09%
-12.7%
NewEROS MEDIA WORLD PLC$60,00025,000
+100.0%
0.06%
AMRN BuyAMARIN CORP PLCspons adr new$52,000
-36.6%
35,000
+40.0%
0.05%
-19.4%
SENS BuySENSEONICS HLDGS INC$47,000
-7.8%
45,500
+75.0%
0.05%
+16.7%
ARAY NewACCURAY INC$41,00021,000
+100.0%
0.04%
BHG NewBRIGHT HEALTH GROUP INC$18,00010,000
+100.0%
0.02%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-07-29
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NEOGENOMICS INC41Q3 20237.8%
LILY ELI & CO41Q3 20236.9%
PFIZER INC41Q3 20232.9%
ATTUNITY LTD41Q3 20233.6%
EXPEDITORS INTL WASH INC41Q3 20232.3%
CVS HEALTH CORP41Q3 20231.6%
DONALDSON INC41Q3 20231.3%
VERIZON COMMUNICATIONS INC41Q3 20231.0%
US BANCORP DEL41Q3 20230.8%
BAXTER INTL INC40Q3 202314.1%

View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.

Latest significant ownerships (13-D/G)
PERKINS CAPITAL MANAGEMENT INC Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
BIOLASE, INCMay 15, 2023689,1962.1%
FlexShopper, Inc.February 09, 20231,281,4605.9%
Avinger IncFebruary 14, 2020891,7615.2%
Black Ridge Oil & Gas, Inc.February 15, 201930,021,0326.3%
CANCER GENETICS, INCFebruary 15, 20191,135,2504.0%
TearLab CorpFebruary 15, 20191,666,29413.1%
Xtant Medical Holdings, Inc.February 15, 2019684,4083.6%
TearLab CorpJanuary 26, 20184,300,65540.1%
BIO KEY INTERNATIONAL INCFebruary 09, 2017274,9004.4%
EnteroMedics IncFebruary 09, 20171,4550.0%

View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-09
13F-HR2024-01-22
13F-HR2023-11-02
13F-HR2023-07-21
SC 13G/A2023-05-15
13F-HR2023-05-09
SC 13G/A2023-02-09
SC 13G2023-02-09
13F-HR2023-01-26
13F-HR2022-10-24

View PERKINS CAPITAL MANAGEMENT INC's complete filings history.

Compare quarters

Export PERKINS CAPITAL MANAGEMENT INC's holdings